HEALTH

Hyland’s holds press conference on homeopathic remedies

BY Michael Johnsen

LOS ANGELES One day before the Food and Drug Administration meets to examine the safety and effectiveness of over-the-counter cough and cold medicines for infants and young children, Hyland’s Wednesday morning hosted a media conference call to highlight homeopathy remedies as a potential alternative to conventional OTC medicines.

Iris Bell, professor of family and community medicine, psychiatry and psychology at the College of Public Health of the University of Arizona College, noted there were several advantages to homeopathic remedies, including “low cost and an excellent safety record over its lengthy history,” she said. “Many people tend to confuse homeopathy as an alternative” to conventional medicine with the full gamut of alternative remedies, including herbal remedies. “In the United States, homeopathic [remedies] are regulated by the FDA” as drugs, Bell said.

Homeopathic remedies are safe and effective, even for children under the age of two, commented Timothy Fior, vice president of the Illinois Homeopathic Medical Association. “Homeopathy is very conducive to self-care,” he said, noting that there aren’t the same overdosing safety concerns with homeopathic remedies as there potentially are with synthetic medicines.

“The voluntary withdrawal of household names in children’s cold relief may cause many parents to believe that their children will have no alternatives in the alleviation of cold symptoms,” Hyland’s stated. “On the contrary, safe, all-natural options exist in the form of homeopathic medicines.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

House passes Dextromethorphan Distribution Act; NACDS, CHPA applaud

BY Michael Johnsen

WASHINGTON Both the Consumer Healthcare Products Association and the National Association of Chain Drug Stores commended the U.S. House of Representatives passing of H.R. 970, the Dextromethorphan Distribution Act of 2007, on Monday, which prohibits the distribution of raw dextromethorphan, an active ingredient commonly found in over-the-counter cough medicines, to any person other than FDA-registered producers of drugs and devices. On that point, NACDS would opt for the approach of Senate companion legislation, which would maintain the availability of bulk DXM to pharmacies for use in compounding.

“Today’s vote demonstrates the commitment of U.S. Reps. Fred Upton, R-Mich., and Rick Larsen, D-Wash. … and the bill’s 22 co-sponsors to protecting America’s youth from this serious threat,” stated Linda Suydam, CHPA president. “This bipartisan legislation is vital to protecting America’s youth from unscrupulous online pushers who willingly provide kids with the raw form of dextromethorphan as a means to get high.

“NACDS and its members are committed to the health of communities,” added Steven Anderson, NACDS president and chief executive officer. “This involves maintaining access to necessary medication and preventing the devastation and tragedy of the drug trade and drug abuse.”

NACDS’ work on this issue demonstrates a commitment to three stated priorities of the association—maintaining and advancing the ability of pharmacies to serve patients as an integral part of the health care system, preventing drug abuse and engaging on issues of importance to both the pharmacy and front-end operations of NACDS members.

To become law, the legislation will need to be passed by the House of Representatives and Senate in identical form, and be signed by the President.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

PacificHealth stays positive on Accelerade despite disappointment by partner Cadbury

BY Michael Johnsen

MATAWAN, N.J. PacificHealth Labs on Monday remained positive behind its launch of Accelerade RTD, despite comments from distribution partner Cadbury Schweppes Americas Beverages that the initial launch of the sports beverage was disappointing.

“The number of total Accelerade servings sold in the third quarter is the highest we have ever seen for this product,” stated Robert Portman, PacificHealth president and chief executive offiicer. “This strongly suggests that our audience of users is expanding. … While Cadbury Schweppes has publicly announced their disappointment in sales of Accelerade RTD to date, we are encouraged by our own increase in sales and we will continue to work closely with the CSAB sales and marketing team.”

PacificHealth also announced it will initiate a number of marketing and sales efforts behind its Satiatrim diet aid, including the launch of radio commercials and ads in Women’s World and a major sampling program.

“At the Obesity Society Annual Scientific Meeting in New Orleans this month [Oct. 20 through 24], a study will be presented showing the effectiveness of Satiatrim on slowing gastric emptying,” Portman said. “These results are laying the foundation to allow us to incorporate the Satiatrim technology into new forms and to develop new products that are even more efficacious with a greater duration of action.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?